GlycoMimetics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GlycoMimetics and other ETFs, options, and stocks.About GLYC
GlycoMimetics, Inc. is a biotechnology company, which engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. The company was founded by Rachel K.
CEOHarout Semerjian, MBA
CEOHarout Semerjian, MBA
Employees26
Employees26
HeadquartersRockville, Maryland
HeadquartersRockville, Maryland
Founded2003
Founded2003
Employees26
Employees26
GLYC Key Statistics
Market cap16.12M
Market cap16.12M
Price-Earnings ratio-0.54
Price-Earnings ratio-0.54
Dividend yield—
Dividend yield—
Average volume324.25K
Average volume324.25K
High today$0.2478
High today$0.2478
Low today$0.2478
Low today$0.2478
Open price$0.26
Open price$0.26
Volume1.41K
Volume1.41K
52 Week high$0.63
52 Week high$0.63
52 Week low$0.1406
52 Week low$0.1406
People also own
Based on the portfolios of people who own GLYC. This list is generated using Robinhood data, and it’s not a recommendation.